The Return of the Venture-Backed IPO

Admittedly, four data points aren’t yet much of a trend, but it’s worth pointing we are seeing the beginnings of a resurgence in the venture-backed IPO market in 2010. So far this year we have seen four non-biotech venture-backed deals, and they have all performed impressively, as the following table shows.


Related posts:

  1. Focused Funds and the Return of the Venture-Backed IPO
  2. Venture-Backed IPO Market Still Mostly Dead
  3. The Death of Venture-Backed IPOs
  4. Venture-Backed IPOs on the Upswing
  5. Expensive CEOs at Venture-backed Companies